Biosensor technology company Allez Health secures $60M

The article discusses California-based Allez Health securing $60 million in Series A+ financing. Allez Health is a continuous glucose monitoring biosensor platform aiming to improve patient performance by analyzing health datasets. The funding will be used for operations, regulatory approval filings, manufacturing scale, and clinical trial acceleration. Allez Health’s team comprises former Dexcom leaders.

Highlights:
1. Allez Health secured $60 million in Series A+ financing led by Osang Healthcare.
2. The company specializes in continuous glucose monitoring biosensor technology.
3. The funding will support operations, regulatory approvals, manufacturing scale, and clinical trials.

Summary: Allez Health, a company focusing on continuous glucose monitoring biosensors, received significant funding to enhance its operations, regulatory approvals, manufacturing processes, and clinical trials. With a team of former Dexcom leaders, the company aims to bring accessible and reliable health solutions to the market.

Editorial content by NewsSIP AI